Company Page

Monash University

Monash University is a world-renowned institution of higher education that is committed to excellence in education, research, and innovation. With a history dating back to 1958, Monash University is one of Australia's leading universities, ranked among the top 100 universities in the world. The university has a diverse student population of over 70,000 students, including international students from over 170 countries.

Monash University is at the forefront of cutting-edge research in the field of clinical psychedelics. Headed by Paul Liknaitzky, the university's Clinical Psychedelic Research program is conducting a series of psychedelic trials aimed at evaluating the therapeutic effects of psychedelics, designing innovative treatment plans, mitigating known risks, exploring potential drawbacks, and understanding therapeutic mechanisms. Additionally, the university is collaborating with the Multidisciplinary Association for Psychedelic Studies (MAPS) to offer an MDMA-assisted therapist training program, which is the first of its kind in the world.

Monash University's commitment to innovation and excellence is evident in its efforts to explore new frontiers in the field of clinical psychedelics. With its world-class research facilities and highly qualified team of experts, Monash University is poised to continue making significant contributions to the field of clinical psychedelics for years to come.